Generation of a homozygous CIITA knockout iPS cell line using the CRISPR-Cas9 system
Human induced pluripotent stem cells (iPSCs) have great promise in regenerative medicine. However, several limitations, including immune-incompatibility, have raised concerns regarding their clinical application. Recent studies have shown that human iPSCs and their derivatives lose their immunogenic...
Main Authors: | Elena Romano, Piera Trionfini, Roberta Giampietro, Ariela Benigni, Susanna Tomasoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S187350612100427X |
Similar Items
-
Generation of PKD1 mono-allelic and bi-allelic knockout iPS cell lines using CRISPR-Cas9 system
by: Elena Romano, et al.
Published: (2020-08-01) -
Generation of two isogenic knockout PKD2 iPS cell lines, IRFMNi003-A-1 and IRFMNi003-A-2, using CRISPR/Cas9 technology
by: Piera Trionfini, et al.
Published: (2020-01-01) -
Generation of two isogenic iPS cell lines (IRFMNi002-A and IRFMNi002-B) from a patient affected by Focal Segmental Glomerulosclerosis carrying a heterozygous c.565G>A mutation in PAX2 gene
by: Osele Ciampi, et al.
Published: (2018-12-01) -
Generation of a homozygous RANGRF knockout hiPSC line by CRISPR/Cas9 system
by: Meiling Jiang, et al.
Published: (2023-09-01) -
Generation of a homozygous TAZ knockout hESCs line by CRISPR/Cas9 system
by: Meng Zhou, et al.
Published: (2022-10-01)